(Q54577112)

1 June 2018

title

Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma. (English)

1 reference

1 June 2018

author name string

Hai-Qiang Mai

1

1 reference

1 June 2018

Zong-Yuan Zeng

2

1 reference

1 June 2018

Kai-Tao Feng

3

1 reference

1 June 2018

Yan-Li Ye

4

1 reference

1 June 2018

Chang-Qing Zhang

5

1 reference

1 June 2018

Wei-Jiang Liang

6

1 reference

1 June 2018

Xiang Guo

7

1 reference

1 June 2018

Hao-Yuan Mo

8

1 reference

1 June 2018

Ming-Huang Hong

9

1 reference

1 June 2018

publication date

9 October 2006

1 reference

1 June 2018

published in

Cancer Science

1 reference

1 June 2018

volume

97

1 reference

1 June 2018

page(s)

1388-1395

1 reference

1 June 2018

issue

12

1 reference

1 June 2018

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Human astrocytoma U138MG cells express predominantly type-A endothelin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Role of endothelin-1 in neovascularization of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin-1 inhibits apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Increased expression of endothelin-1 and its mitogenic receptor ETA in human papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin-1: a multifunctional molecule in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

The endothelin axis: emerging role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin receptors as novel targets in tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin receptor antagonists in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin-1 promotes proteolytic activity of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

Photoisomerization of a rotaxane hydrogen bonding template: light-induced acceleration of a large amplitude rotational motion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00333.X

10.1111/J.1349-7006.2006.00333.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

17032313

1 reference

1 June 2018